Chemoradiotherapy of NSCLC Stage IIIB

This study has been completed.
Sponsor:
Collaborators:
Bristol-Myers Squibb
Pierre Fabre Laboratories
Ligue contre le cancer, France
Information provided by:
Intergroupe Francophone de Cancerologie Thoracique
ClinicalTrials.gov Identifier:
NCT00198432
First received: September 13, 2005
Last updated: March 9, 2016
Last verified: March 2016